A Novel GUCY2C-CD3 T cell Engaging Bispecific construct (PF-07062119) for the Treatment of Gastrointestinal Cancers.

CONCLUSION: These data highlight the potential for PF-07062119 to demonstrate efficacy and improve patient outcomes in CRC and other gastrointestinal malignancies. PMID: 31996389 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31996389?dopt=Abstract

Source: Clinical Cancer Research - January 28, 2020 Category: Cancer & Oncology Authors: Mathur D, Root AR, Bugaj-Gaweda B, Bisulco S, Tan X, Fang W, Kearney JC, Lucas J, Guffroy M, Golas J, Rohde CM, Stevens C, Kamperschroer C, Kelleher K, Lawrence-Henderson RF, Upeslacis E, Yao J, Narula J, LaVallie ER, Fernandez DR, Buetow BS, Rosfjord E, Tags: Clin Cancer Res Source Type: research